Clinical Trials Directory

Trials / Unknown

UnknownNCT01980134

The MORDIS Study Clinical Investigational Plan

Multicenter, Open, Prospective Study on Modified Resect and DIScard Strategy of Small Colonic Lesions Using WavSTAT4 Optical Biopsy System: The MORDIS Study Clinical Investigational Plan

Status
Unknown
Phase
Study type
Observational
Enrollment
1,200 (estimated)
Sponsor
SpectraScience · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

To demonstrate the use of WavSTAT4 system during colonoscopy in identifying diminutive colorectal lesions (e.g. hyperplastic polyps) that can be resected and discarded (or even left in-situ) without adverse clinical impact.

Detailed description

To demonstrate the performance of the WavSTAT4 Optical Biopsy System when used at multiple centers. Endpoint targets are based on the ASGE PIVI recommendations on real-time endoscopic assessment of the histology of diminutive colorectal polyps. * Primary endpoint: To demonstrate potential of the WavSTAT4 Optical Biopsy System to predict adenomatous histology with a NPV \> = 90% for diminutive colorectal lesions. * Secondary Endpoint: To show that use of the WavSTAT4 system used to determine histology of colorectal polyps ≤5 mm in size, when combined with the histo- pathologic assessment of polyps \>5 mm in size, provides a ≥ 90% agreement in assignment of post-polypectomy surveillance intervals when compared to decisions based on pathology assessment of all identified polyps.

Conditions

Timeline

Start date
2013-12-01
Primary completion
2016-08-01
Completion
2016-11-01
First posted
2013-11-08
Last updated
2016-04-14

Locations

6 sites across 5 countries: Czechia, Denmark, Germany, Italy, Sweden

Source: ClinicalTrials.gov record NCT01980134. Inclusion in this directory is not an endorsement.